Morbidity and Embolic Potential of Left Atrial Cardiac Tumors

Abstract

Background: The aim of the study was to correlate cardiac tumors with implantation site, embolic potential and long-term evolution in patients undergoing surgery. Methods: From 1981 to 2004, 78 patients underwent surgery for cardiac tumors. 64 % were female, with a mean age of 44 years. 14 % had embolic episodes (91 % CVA). The sizes of the tumors ranged from 0.4 cm to 10 cm. The most frequent tumors were myxomas (70 %), papillary fibroelastomas and fibromas. The preferential location was the left atrium (72 %). Data were analyzed using χ² and Student's t-tests, and the Kaplan-Meyer method and curves were compared with the log-rank test. Results: Hospital mortality was 6 % and 8.2 % in the follow-up period. Myxoma was predominantly found in the left atrium (p < 0.0001; OR = 12.8 and 4 - 41 95 % CI). Left atrial tumors showed less mortality (p = 0.1; OR = 3 and 0.7 - 11.6 95 % CI), with a lower mortality for myxomas (p < 0.001), fewer recurrences (p = 0.03; OR = 8.7 and 0.8 - 89 95 % CI), and a greater embolic potential than in other locations (p = 0.03 % OR = 0.7 and 0.6 - 0.8 95 % CI). Conclusion: Left atrial tumors showed greater embolic potential, fewer recurrences and less mortality.

Key words

Primary cardiac tumors - left atrial tumors - embolization

References

• 1 Bakaeen F G, Reardon M J, Coselli J S. et al . Surgical outcome in 85 patients with primary cardiac tumors.  Am J Surg. 2003;  186 641-647
• 2 Kamiya H, Yasuda T, Nagamine H. et al . Surgical treatment of primary cardiac tumors - 28 years' experience in Kanazawa University Hospital.  Jpn Circ J. 2001;  65 315-319
• 3 Gowda R M, Khan I A, Nair C K, Mehta N J, Vasavada B C, Sacchi T J. Cardiac papillary fibroelastoma: a comprehensive analysis of 725 cases.  Am Heart J. 2003;  146 404-410
• 4 Isaacs Jr H. Fetal and neonatal cardiac tumors.  Pediatr Cardiol. 2004;  25 252-273
• 5 Centofanti P, Rosa E D, Deorsola L. et al . Primary cardiac tumors: early and late results of surgical treatment in 91 patients.  Ann Thorac Surg. 1999;  68 1236-1241
• 6 Keeling I M, Oberwalder P, Anelli-Monti M. et al . Cardiac myxomas: 24 years of experience in 49 patients.  Eur J Cardiothorac Surg. 2002;  22 971-977
• 7 Bjessmo S, Ivert T. Cardiac myxoma: 40 years' experience in 63 patients.  Ann Thorac Surg. 1997;  63 697-700
• 8 Bradham R R, Gregorie Jr H B, Howell Jr J S. et al . Aortic obstruction from embolizing cardiac myxoma.  JSC Med Assoc. 1979;  75 7-10
• 9 Schaff H V, Mullany C J. Surgery for cardiac myxomas.  Sem Thorac Cardiovasc Surg. 2000;  12 77-88
• 10 McCarthy P M, Piehler J M, Schaff H V. et al . The significance of multiple, recurrent, and complex cardiac myxomas.  J Thorac Cardiovasc Surg. 1986;  91 389-396
• 11 Ha J W, Kang W C, Chung N. et al . Echocardiographic and morphologic characteristics of left atrial myxoma and their relation to systemic embolism.  Am J Cardiol. 1999;  83 1579-1582
• 12 Kabbani S S, Jokhander M, Meada R. et al . Atrial myxoma: report of 24 operations using the biatrial approach.  Ann Thorac Surg. 1994;  58 483-488
• 13 Wold L E, Lie J T. Cardiac myxomas: a clinicopathologic profile.  Am J Pathol. 1980;  101 219-240
• 14 McCarthy P M, Schaff H V, Winkler H Z. et al . Deoxyribonucleic acid ploidy pattern of cardiac myxomas.  J Thorac Cardiovasc Surg. 1989;  98 1083-1086
• 15 Reynen K. Cardiac myxomas.  N Engl J Med. 1995;  33 1610-1617